Evidensa
HTA, pharmacoeconomic and market access consulting for healthcare technology companies entering Slovakia's reimbursement system
Highlights
- Young companyFounded 2023
- ProfitableFY2025 net profit €150k · RÚZ
- GrowingRevenue +42% YoY (FY2025) · RÚZ
- New on EvolcAdded 2026-10-17
About Evidensa
Evidensa provides consulting on market access and health technology assessment (HTA) for medicines and other healthcare technologies seeking inclusion in Slovakia's reimbursement system. Services include pharmacoeconomic analyses, reimbursement application support, evidence synthesis and training.
Its customers are organizations seeking reimbursement for healthcare technologies, though the website does not specify customer types. The company is registered in Zvolen, Slovakia, and was founded in 2023. It lists a Junior Project Manager (HTA) opening.
Product: Market access and HTA consulting, pharmacoeconomic analyses, reimbursement application support, evidence reviews and training.
Financials
| FY2025 | FY2024 | FY202310 months | |
|---|---|---|---|
| Revenue | €449k | €316k | €128k |
| Growth | +42% | — | — |
| EBITDA | €210k | €114k | €53k |
| Operating profit | €192k | €112k | €52k |
| Net profit | €150k | €86k | €41k |
| Net margin | 33.3% | 27.2% | 32.1% |
| Personnel costs | €157k | €111k | €32k |
| Total assets | €280k | €206k | €91k |
| Cash | €16k | €14k | €32k |
| Liabilities | €125k | €84k | €45k |
| Equity | €155k | €122k | €46k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Open jobs
Leadership
- Jakub Kuchar · Konateľ (Managing director)Source: business register
- Marek Psota · Konateľ (Managing director)Source: business register
Tech stack
- Bootstrap
- Cloudflare
- Google Tag Manager
- Google reCAPTCHA
- jQuery